A1BD3

enprofylline

Created:2024-10-22
Last modified:  2024-10-30

Find related ligands:

Chemical Details

Formal Charge0
Atom Count24
Chiral Atom Count0
Bond Count25
Aromatic Bond Count5
2D diagram of A1BD3

Chemical Component Summary

Nameenprofylline
Systematic Name (OpenEye OEToolkits)3-propyl-7~{H}-purine-2,6-dione
FormulaC8 H10 N4 O2
Molecular Weight194.191
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs14.52O=C1NC(=O)N(CCC)c2nc[NH]c21
SMILESCACTVS3.385CCCN1C(=O)NC(=O)c2[nH]cnc12
SMILESOpenEye OEToolkits3.1.0.0CCCN1c2c([nH]cn2)C(=O)NC1=O
Canonical SMILESCACTVS3.385 CCCN1C(=O)NC(=O)c2[nH]cnc12
Canonical SMILESOpenEye OEToolkits3.1.0.0 CCCN1c2c([nH]cn2)C(=O)NC1=O
InChIInChI1.06 InChI=1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14)
InChIKeyInChI1.06 SIQPXVQCUCHWDI-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB00824 
NameEnprofylline
Groups
  • approved
  • experimental
DescriptionEnprofylline is a derivative of theophylline which shares bronchodilator properties. Enprofylline is used in asthma, chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. Long-term enprofylline administration may be associated with elevation in liver enzyme levels and unpredictable blood levels.
Synonyms
  • 3-n-propylxanthine
  • Enprofyllinum
  • 3-Propyl-3,7-dihydro-purine-2,6-dione
  • 3-propylxanthine
  • Enprofilina
IndicationUsed in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Categories
  • Adenosine A2 Receptor Antagonists
  • Alkaloids
  • Anti-Asthmatic Agents
  • Autonomic Agents
  • Bronchodilator Agents
CAS number41078-02-8

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
3',5'-cyclic-AMP phosphodiesterase 4BMKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNL...unknowninhibitor
5'-nucleotidaseMCPRAARAPATLLLALGAVLWPAAGAWELTILHTNDVHSRLEQTSEDSSK...unknowninhibitor
Adenosine receptor A2bMLLETQDALYVALELVIAALSVAGNVLVCAAVGTANTLQTPTNYFLVSLA...unknownantagonist
3',5'-cyclic-AMP phosphodiesterase 4AMEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSD...unknowninhibitor
Adenosine receptor A1MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVS...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 1676
ChEMBL CHEMBL279898
ChEBI CHEBI:126237